<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2017-62-5-171-174</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-572</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИНФЕКЦИОННЫЕ БОЛЕЗНИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INFECTIOUS DISEASES</subject></subj-group></article-categories><title-group><article-title>Сравнительная эффективность различных схем терапии ротавирусных гастроэнтеритов у детей. Исследование случай–контроль</article-title><trans-title-group xml:lang="en"><trans-title>Comparative efficacy of different schemes for the therapy of rotavirus gastroenteritis in children. Case–control study</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Халиуллина</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Khaliullina</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., доц. кафедры детских инфекций Казанского государственного медицинского университета</p><p>420012 Казань, ул.Бутлерова, д. 49</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Анохин</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Anokhin</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф., зав. кафедрой детских инфекций Казанского государственного медицинского университета</p><p>420012 Казань, ул.Бутлерова, д. 49</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Николаева</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikolaeva</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., проф., зав. кафедрой инфекционных болезней Казанского государственного медицинского университета</p><p>420012 Казань, ул.Бутлерова, д. 49</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Назарова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nazarova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., ассистент кафедры эпидемиологии и доказательной медицины Казанского  государственного медицинского университета</p><p>420012 Казань, ул.Бутлерова, д. 49</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan Medical University, Ministry of Health of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>12</day><month>11</month><year>2017</year></pub-date><volume>62</volume><issue>5</issue><fpage>171</fpage><lpage>174</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/572">https://www.ped-perinatology.ru/jour/article/view/572</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: сравнение эффективности различных видов терапии ротавирусных гастроэнтеритов у детей. Проведено исследование, дизайн которого соответствовал типу  случай–контроль. Основная группа – 35 детей, госпитализированных в стационар с  лабораторно подтвержденной ротавирусной инфекцией, которым назначалась современная  схема терапии: низкоуглеводная диета, регидратация низкоосмолярными пероральными  растворами, смектит диоктаэдрический, пробиотик, содержащий Saccharomyces boulardii.  Пациентам группы сравнения (n=35) назначали традиционную «старую» схему терапии:  диету, соответствующую столу № 4 по Певзнеру, оральные регидратационные растворы с  осмолярностью 282 мОсм/л, антибактериальную терапию (цефтриаксон), смектит  диоктаэдрический и панкреатин – в возрастных дозировках. Длительность наблюдения составила 5 дней.</p></sec><sec><title>Результаты</title><p>Результаты. К 5-му дню лечения нормализация стула зарегистрирована у 91,4% [95% ДИ 82,1–100,7] – у 32 из 35 детей в основной группе и у 71,4% [95% ДИ 56,5–86,3] – у 25 из  35 детей в группе сравнения, (р&lt;0,05, OR 4,27 [95% ДИ 1,06–17,2]). Сроки купирования  синдрома избыточного газообразования также имели статистически значимые различия и  были меньше у пациентов, получавших «новую» схему терапии (OR 2,8 [95% ДИ 1,01–8]).  Положительный эффект от предложенной схемы также наблюдали при оценке длительности  симптомов обезвоживания и сроков госпитализации.</p></sec><sec><title>Выводы</title><p>Выводы. Проведенное исследование случай–контроль показало преимущество современных схем терапии ротавирусной инфекции у детей.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective research</title><p>Objective research: compare the efficacy of different types of therapy for rotavirus gastroenteritis in children.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A study was carried out, the design of which corresponded to the case–control type. The main group is children hospitalized in a hospital with laboratory confirmed rotavirus infection (35 cases), who were prescribed a modern regimen of therapy that included a low-carbohydrate diet, rehydration with low osmolar oral solutions, dioctahedral smectite, probiotic containing Saccharomyces boulardii. For each child of the main group was selected another patient (control), the corresponding sex, age, the period from the onset of the disease to admission to hospital, and the degree of dehydration. Patients of the control group (n=35) were assigned a traditional «old» therapy regimen, including a diet corresponding to Table No. 4 in Pevznur, oral rehydration solutions with osmolality of 282 mOsm/l, anthibacterial therapy (ceftriaxone), dioctahedral smectite and pancreatin at age-dependent doses. The duration of the observation was 5 days.</p></sec><sec><title> </title><p> </p></sec><sec><title>Results</title><p>Results: By the 5th day of treatment, the normalization of the stool was recorded in 91.4% [95% CI 82.1–100.7], 32/35 in the main group and 71.4% [95% CI 56.5–86.3], 25/35 children in the control (p &lt;0.05, OR 4.27 [95% CI 1.06–17.2]). The timing of relief of excess meteorism also had statistically significant differences and was shorter in patients receiving a «new» therapy regimen (OR 2.8 [95% CI 1.01–8])). The positive effect of the proposed scheme was also observed when assessing the duration of dehydration symptoms and the timing of hospitalization.</p></sec><sec><title>Conclusions</title><p>Conclusions: The conducted study case–control showed the advantage of modern schemes of therapy of rotavirus infections in children.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>ротавирусный гастроэнтерит</kwd><kwd>лечение</kwd><kwd>низкоосмолярные растворы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>children</kwd><kwd>rotavirus gastroenteritis</kwd><kwd>treatment</kwd><kwd>low osmolar solutions</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Farthing M., Salam M., Lindberg G. Acute diarrhea in adults and children: a global perspective. World Gastroenterology Organisation Global Guidelines. 2012. http://www.worldgastroenterology.org/guidelines/global-guidelines/acute-diarrhea/acute-diarrhea-russian Ссылка активна на 06.07.2017.</mixed-citation><mixed-citation xml:lang="en">Farthing M., Salam M., Lindberg G. Acute diarrhea in adults and children: a global perspective. World Gastroenterology Organisation Global Guidelines. 2012. http://www.worldgastroenterology.org/guidelines/global-guidelines/acute-diarrhea/acute-diarrhea-russian Ссылка активна на 06.07.2017.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">King C.K., Glass R., Bresee J.S., Duggan C. The Management of Acute Diarrhea in Children: Oral Rehydration, Maintenance, and Nutritional Therapy. СDC. MMWR. 2003. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5216a1.htm Ссылка активна на 06.07.2017.</mixed-citation><mixed-citation xml:lang="en">King C.K., Glass R., Bresee J.S., Duggan C. The Management of Acute Diarrhea in Children: Oral Rehydration, Maintenance, and Nutritional Therapy. СDC. MMWR. 2003. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5216a1.htm Ссылка активна на 06.07.2017.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Global burden of disease. Health Metrics and Evaluation (IHME), University of Washington, 2013. http://www.healthdata.org/sites/default/files/files/policy_report/2013/WB_EuropeCentralAsia/IHME_GBD_WorldBank_EuropeCentralAsia_FullReport_RUSSIAN.pdf Ссылка активна на 06.07.2017.</mixed-citation><mixed-citation xml:lang="en">Global burden of disease. Health Metrics and Evaluation (IHME), University of Washington, 2013. http://www.healthdata.org/sites/default/files/files/policy_report/2013/WB_EuropeCentralAsia/IHME_GBD_WorldBank_EuropeCentralAsia_FullReport_RUSSIAN.pdf Ссылка активна на 06.07.2017.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Guarino А., Ashkenazi S., Gedrel D. ESPGHAN/ESPID Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe. Update 2014. J Pediatr Gastroenterol Nutr 2014; 59 (1): 132–152. DOI: 10.1097/MPG.0000000000000375</mixed-citation><mixed-citation xml:lang="en">Guarino А., Ashkenazi S., Gedrel D. ESPGHAN/ESPID Evidence-based Guidelines for the Management of Acute Gastroenteritis in Children in Europe. Update 2014. J Pediatr Gastroenterol Nutr 2014; 59 (1): 132–152. DOI: 10.1097/MPG.0000000000000375</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Szajewska H. Advances and limitations of evidence-based medicine – impact for probiotics. Ann Nutr Metab 2010; 57: 6–9. DOI: 10.1159/000309015.</mixed-citation><mixed-citation xml:lang="en">Szajewska H. Advances and limitations of evidence-based medicine – impact for probiotics. Ann Nutr Metab 2010; 57: 6–9. DOI: 10.1159/000309015.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Olek A., Woynarowski M., Ahren I.L., Kierkuś J., Socha P., Larsson N., Önning G. Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic- Associated Gastrointestinal Symptoms in Children-Randomized, Double-Blind, Placebo- Controlled Study. J Pediatr 2017; 186: 82-86. DOI: 10.1016/j.jpeds.2017.03.047.</mixed-citation><mixed-citation xml:lang="en">Olek A., Woynarowski M., Ahren I.L., Kierkuś J., Socha P., Larsson N., Önning G. Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic- Associated Gastrointestinal Symptoms in Children-Randomized, Double-Blind, Placebo- Controlled Study. J Pediatr 2017; 186: 82-86. DOI: 10.1016/j.jpeds.2017.03.047.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
